Variant Creutzfeldt-Jakob disease: An unfolding epidemic of misfolded proteins

被引：4

作者：

Horby, P ^{[1
]}

机构：

[1] Childrens Hosp, Natl Ctr Immunisat Res & Surveillance Vaccine Pre, Westmead, NSW, Australia

来源：

JOURNAL OF PAEDIATRICS AND CHILD HEALTH | 2002年 / 38卷 / 06期

关键词：

control; epidemiology; pathogenesis; variant Creutzfeldt-Jakob disease;

D O I：

10.1046/j.1440-1754.2002.00055.x

中图分类号：

R72 [儿科学];

学科分类号：

100202 ;

摘要：

Variant Creutzfeldt-Jakob disease (vCJD) is an emerging infectious disease believed to be the human manifestation of bovine spongiform encephalopathy (BSE). Variant CJD belongs to a family of human and animal diseases called transmissible spongiform encephalopathies (TSE). The pathogenesis of TSE is not fully understood, but a modified form of a normal cellular protein plays a central role. Current measures to control vCJD aim to prevent transmission of the infectious agent from animals to humans through food or pharmaceutical products and to prevent transmission from person to person via medical interventions. The anticipated development of preclinical diagnostic tests and treatments for vCJD will create new control options and difficult choices.

引用

页码：539 / 542

页数：4

共 35 条

[1] Codon 129 prion protein genotype and sporadic Creutzfeldt-Jakob disease [J].

Alperovitch, A ;

Zerr, I ;

Pocchiari, M ;

Mitrova, E ;

Cuesta, JD ;

Hegyi, I ;

Collins, S ;

Kretzschmar, H ;

van Duijn, C ;

Will, RG .

LANCET, 1999, 353 (9165) :1673-1674

[2]

Boyd A, 2001, Commun Dis Intell Q Rep, V25, P248

[3]

Brooke F J, 2001, Commun Dis Intell Q Rep, V25, P99

[4] HUMAN SPONGIFORM ENCEPHALOPATHY - THE NATIONAL-INSTITUTES-OF-HEALTH SERIES OF 300 CASES OF EXPERIMENTALLY TRANSMITTED DISEASE [J].

BROWN, P ;

GIBBS, CJ ;

RODGERSJOHNSON, P ;

ASHER, DM ;

SULIMA, MP ;

BACOTE, A ;

GOLDFARB, LG ;

GAJDUSEK, DC .

ANNALS OF NEUROLOGY, 1994, 35 (05) :513-529

[5] Further studies of blood infectivity in an experimental model of transmissible spongiform encephalopathy, with an explanation of why blood components do not transmit Creutzfeldt-Jakob disease in humans [J].

Brown, P ;

Cervenáková, L ;

McShane, LM ;

Barber, P ;

Rubenstein, R ;

Drohan, WN .

TRANSFUSION, 1999, 39 (11-12) :1169-1178

[6] Detection of variant Creutzfeld-Jakob disease infectivity in extraneural tissues [J].

Bruce, ME ;

McConnell, I ;

Will, RG ;

Ironside, JW .

LANCET, 2001, 358 (9277) :208-209

[7] Transmissions to mice indicate that 'new variant' CJD is caused by the BSE agent [J].

Bruce, ME ;

Will, RG ;

Ironside, JW ;

McConnell, I ;

Drummond, D ;

Suttie, A ;

McCardle, L ;

Chree, A ;

Hope, J ;

Birkett, C ;

Cousens, S ;

Fraser, H ;

Bostock, CJ .

NATURE, 1997, 389 (6650) :498-501

[8] MICE DEVOID OF PRP ARE RESISTANT TO SCRAPIE [J].

BUELER, H ;

AGUZZI, A ;

SAILER, A ;

GREINER, RA ;

AUTENRIED, P ;

AGUET, M ;

WEISSMANN, C .

CELL, 1993, 73 (07) :1339-1347

[9] MRI of Creutzfeldt-Jakob disease: Imaging features and recommended MRI protocol [J].

Collie, DA ;

Sellar, RJ ;

Zeidler, M ;

Colchester, ACF ;

Knight, R ;

Will, RG .

CLINICAL RADIOLOGY, 2001, 56 (09) :726-739

[10] Molecular analysis of prion strain variation and the aetiology of 'new variant' CJD [J].

Collinge, J ;

Sidle, KCL ;

Meads, J ;

Ironside, J ;

Hill, AF .

NATURE, 1996, 383 (6602) :685-690

← 1 2 3 4 →